Investing in microcap stocks are considered to be risky; even higher so in uncertain market environments like the one we are seeing
Biocept (BIOC) – Is it worth buying?
Categories
Health Care
Simulations Plus Inc (NASDAQ: SLP) Q3 2020 Earnings Call Transcript
Simulations Plus Inc (SLP) Q3 2020 earnings call dated July 09, 2020 Corporate Participants: Cameron Donahue -- Partner and Regional Vice President Shawn O'Connor -- Chief
Walgreens Boots Alliance Inc. (WBA) Q3 2020 Earnings Call Transcript
Walgreens Boots Alliance Inc. (WBA) Q3 2020 earnings call dated July 09, 2020 Corporate Participants: Gerald Gradwell -- Senior Vice President of Investor Relations
Avid Bioservices, Inc. (NASDAQ: CDMO) Q4 2020 Earnings Call Transcript
Avid Bioservices, Inc. (CDMO) Q4 2020 earnings call dated June 30, 2020 Corporate Participants: Tim Brons -- Executive Vice President Rick Hancock -- Interim President and
Rite Aid (RAD) Q1 2021 earnings results: Is this a permanent turnaround?
It's been a disappointing first half for drugstore chain operators. However, after reporting better-than-expected top and bottom line figures for its first
Centogene N.V. (NASDAQ: CNTG) Q1 2020 Earnings Call Transcript
Centogene N.V. (CNTG) Q1 2020 earnings call dated June 15, 2020 Corporate Participants: Sun Kim -- Chief Strategy & Investor Relations Officer, Chief Business
Nektar Therapeutics (NASDAQ: NKTR) Q1 2020 Earnings Call Transcript
Nektar Therapeutics (NKTR) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Jennifer Ruddock -- Senior Vice President, Strategy and Corporate Affairs Howard
Penumbra Inc (NYSE: PEN) Q1 2020 Earnings Call Transcript
Penumbra Inc (PEN) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Jee Hamlyn-Harris -- Investor Relations Adam Elsesser -- Chairman and Chief Executive Officer
ICU Medical Inc (NASDAQ: ICUI) Q1 2020 Earnings Call Transcript
ICU Medical Inc (ICUI) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: John F. Mills -- Managing Partner Vivek Jain -- Chairman of the
Globus Medical Inc (NYSE: GMED) Q1 2020 Earnings Call Transcript
Globus Medical Inc (GMED) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Brian J. Kearns -- Investor Relations David M. Demski -- President and
Rite Aid Corp (NYSE: RAD) Q1 2021 Earnings Call Transcript
Rite Aid Corp (RAD) Q1 2021 earnings call dated June 25, 2020 Corporate Participants: Byron Purcell -- Treasurer & Investor Relations Heyward Donigan -- President and
Rite Aid (RAD) posts narrower-than-expected loss in Q1
Rite Aid Corporation (NYSE: RAD) reported a narrower loss in the first quarter of fiscal 2021 as an increase in the store
Amarin (AMRN) stock to remain within a tight range until the end of Vascepa litigation
The patent war between Amarin (NASDAQ: AMRN) and the generic companies for cardiovascular drug Vascepa continues to be a headwind for Amarin.
Patterson Companies Inc (NASDAQ: PDCO) Q4 2020 Earnings Call Transcript
Patterson Companies Inc (PDCO) Q4 2020 earnings call dated Jun. 24, 2020 Corporate Participants: John M. Wright -- Vice President of Investor Relations Mark
Cantel Medical Corp. (NYSE: CMD) Q3 2020 Earnings Call Transcript
Cantel Medical Corp. (CMD) Q3 2020 earnings call dated Jun. 04, 2020 Corporate Participants: Matthew Micowski -- Vice President, FP&A and Investor Relations George
Affimed N.V. (NASDAQ: AFMD) Q1 2020 Earnings Call Transcript
Affimed N.V. (AFMD) Q1 2020 earnings call dated Jun. 23, 2020 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi Hoess -- Chief Executive Officer
Cooper Companies Inc (NYSE: COO) Q2 2020 Earnings Call Transcript
Cooper Companies Inc (COO) Q2 2020 earnings call dated Jun. 04, 2020 Corporate Participants: Kim Duncan -- Vice President, Investor Relations and Risk Management
Neptune Wellness Solutions Inc (NASDAQ: NEPT) Q4 2020 Earnings Call Transcript
Neptune Wellness Solutions Inc (NEPT) Q4 2020 earnings call dated June 10, 2020 Corporate Participants: Scott Van Winkle -- Investor Relations, ICR Michael Cammarata -- President
Eli Lilly (LLY) appears to be on a strong footing with COVID-19 drug development efforts
Eli Lilly & Co.’s (NYSE: LLY) shares have gained 29% since the beginning of the year and 16% over the past three
FibroGen Inc (NASDAQ: FGEN) Q1 2020 Earnings Call Transcript
FibroGen Inc (FGEN) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Michael Tung -- Corporate Strategy Investor Relations Enrique Conterno -- Chief Executive Officer
Veeva Systems Inc (NYSE: VEEV) Q1 2021 Earnings Call Transcript
Veeva Systems Inc (VEEV) Q1 2021 earnings call dated May 28, 2020 Corporate Participants: Rick Lund -- Head of Investor Relations Peter Gassner -- Founder and